Sort
53,477 grants matching “addiction”
SUMOylation disruption is toxic for SS18-SSX-driven synovial sarcoma
$571,084Anthony Charles Faber · Virginia Commonwealth University · R01 · FY2023 · CA
Identification of small molecules that regulate endogenous opioid signaling by inhibiting angiotensin converting enzyme
$571,020Swati S More · University Of Minnesota · R01 · FY2024 · DA
Functionally selective D2Rs, striatal circuit function and motivation
$571,012Christoph Kellendonk · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2016 · MH
Expanding Medication Assisted Therapies in Central Asia
$571,007Frederick Lewis Altice · Yale University · R01 · FY2024 · DA
Large-scale analysis of functional synapses during circuit plasticity with novel optogenetic sensors
$570,993Karen Zito · University Of California At Davis · U01 · FY2017 · NS
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes
$570,942Mahendra Kumar · University Of Miami School Of Medicine · R01 · FY2015 · DA
Next-Generation Mouse Models of Endometrial Cancer
$570,932Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2017 · CA
Next-Generation Mouse Models of Endometrial Cancer
$570,932Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2019 · CA
Online Training Support System for Community-Based Substance Abuse Agencies
$570,927Jaime Lynn Houston Mulligan · Sheidow Consulting, Inc. · R44 · FY2015 · DA
Cognitive Therapy for the Prevention of Suicide
$570,807Aaron T Beck · University Of Pennsylvania · P20 · FY2006 · MH
Maternal Lifestyle Study 12-15 Year Follow Up.
$570,806Charles R Bauer · University Of Miami School Of Medicine · U10 · FY2009 · DA
CESSATION IN HEAVY SMOKERS USING NRT AND ADJUVANT VIDEO
$570,758Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
$570,758Yan Xu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · NS
Design, synthesis and characterization of dopamine receptor 3 ligands
$570,748Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2007 · DA
Rodents with Genetic Differences in Alcohol Preference
$570,710Richard Lowell Bell · Indiana University Indianapolis · R24 · FY2014 · AA
Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission
$570,636Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2019 · DA
Translational addiction neurobiology
$570,591Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2013 · DA
Enhanced Linkage of Drug Abusers to Primary Medical Care
$570,576Jeffrey H Samet · Boston Medical Center · R01 · FY2010 · DA
Yakama Nation: Native Collective Research Effort to Enhance Wellness Program
$570,523Katherine R Saluskin · Yakama Tribal Council D/B/A Confederated Tribes And Bands Of The Yakama Nation · OT2 · FY2025 · DA
Intervention for Teens with ADHD and Substance Use
$570,518William E Pelham · Florida International University · R01 · FY2015 · DA
Safety of Nicotine Reduction Strategy
$570,509Neal L Benowitz · University Of California, San Francisco · R01 · FY2007 · CA
Long Term THC Elicits Distinct Changes in Adolescent Brain Dopamine Signaling
$570,509Bertha K Madras · Mclean Hospital · R01 · FY2018 · DA
Isoflavone Treatment for Alcohol Abuse
$570,503Scott E Lukas · Mclean Hospital · R01 · FY2009 · AA
Center for Dissemination and Implementation At Stanford (C-DIAS): Administrative Core
$570,501Mark P. McGovern · Stanford University · P50 · FY2022 · DA
Center for Dissemination and Implementation At Stanford (C-DIAS): Research Core
$570,500Lisa Saldana · Stanford University · P50 · FY2022 · DA